- Home
- » Tags
- » Procarbazine
Top View
- Emetogenic Potential of Antineoplastic Agents
- Computationally Predicting Clinical Drug Combination Efficacy With
- As Initial Treatment for Hodgkin Lymphoma
- Hodgkin's Disease
- Biweekly THP-COPBLM (Pirarubicin, Cyclophosphamide, Vincristine
- Chemotherapy
- From Old Alkylating Agents to New Minor Groove Binders
- Adult Antiemetic Management of Chemotherapy-Induced Nausea
- Fertility Following Contemporary Chemotherapy in Childhood Cancer Survivors
- List of Off-Patent, Off-Exclusivity Drugs Without an Approved Generic
- North Carolina Division of Health Benefits Physician Administered Drug Program Catalog
- Clinical Response and Pharmacokinetics of Bendamustine As a Component of Salvage R-B(O)AD Therapy for the Treatment of Primary C
- List of Drug Names & Synonyms
- Vincristine in Combination Therapy of Cancer: Emerging Trends in Clinics
- BRAIN CANCER TREATMENT REGIMENS (Part 1 of 9) Clinical Trials: the NCCN Recommends Cancer Patient Participation in Clinical Trials As the Gold Standard for Treatment
- Clinical Challenges in Caring for Patients with Diabetes and Cancer
- Prognosticfactors in Patientswith Advancedstage Prostatecancer1
- Guideline for Classification of the Acute Emetogenic Potential of Antineoplastic Medication in Pediatric Cancer Patients
- Inhibition of Malignant Glial Cell Growth by Estramustine, an Estrogen
- DRUG NAME Toxicities: Acute: Delayed: Subclass Mechanism of Action
- THP-COPBLM (Pirarubicin, Cyclophosphamide
- Rescue Protocols for Canine Lymphoma
- Cancer Drug Costs for a Month of Treatment at Initial Food and Drug
- Download Master-Thesis
- Review of Treatment Options for the Management of Advanced Stage Hodgkin Lymphoma
- High-Dose Methotrexate-Based Regimens and Post-Remission
- Primary Central Nervous System Lymphoma: a Narrative Review of Ongoing Clinical Trials and Goals for Future Studies
- Anticancer Potential of Cephalotaxine and Derivatives As an Alternative for Invasive Therapies 2
- Clinical Policy: Bendamustine (Bendeka, Treanda)
- Gynaecomastia: Aetiology and Treatment Options
- Combination Chemotherapy with Mitomycin-C, Ifosfamide And
- Clinical Report
- Hypersensitivity Reactions to Anticancer Agents
- RMP (Rituximab, Methotrexate, Procarbazine) Primary CNS
- Hazardous Drug List
- Bendeka, Treanda) Reference Number: ERX.SPA.268 Effective Date: 12.01.18 Last Review Date: 11.20 Line of Business: Commercial, Medicaid Revision Log